Links between the Oral Microbiota and Pulmonary Disease
Frank A. Scannapieco, DDSSaturday, February 8
9:00 am - 9:45 am
Associations between poor oral health and pulmonary diseases are possible through a variety of mechanisms. This presentation will provide an overview of the latest information on the problems of aspiration pneumonia and nosocomial-acquired pneumonia, especially ventilator-associated pneumonia (VAP). Both infections lead to serious consequences for morbidity and mortality in institutional settings. Results from a recent randomized trial that tested the effects of the oral topical antimicrobia chlorhexidine on the oral flora of ventilated patients will be presented. Biologic mechanisms involving the oral microflora and host response that influence pneumonia will be discussed. Practical advice on how to translate this information into everyday practice will be presented.